Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Piperno

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Hepatology (Baltimore, Md.)|September 4, 2010
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosisPradyumna Phatak, Pierre Brissot, Mark Wurster, et al.
Acta Neuropathologica|June 1, 2013
Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulationDorota Dziewulska, Hiroshi Doi, Alfonso Fasano, et al.
Journal of Inherited Metabolic Disease|February 10, 2018
Hepatocellular carcinoma in Gaucher disease: an international case seriesMartine Regenboog, Laura van Dussen, Joanne Verheij, et al.
Genes|December 24, 2021
New Mutations in <i>HFE2</i> and <i>TFR2</i> Genes Causing Non <i>HFE</i>-Related Hereditary HemochromatosisGonzalo Hernández, Xenia Ferrer-Cortès, Veronica Venturi, et al.
Journal of Personalized Medicine|September 23, 2022
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case ReportsMatteo Marcatili, Riccardo Borgonovo, Noemi Cimminiello, et al.
Hepatology International|March 29, 2018
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotypePaul Adams, Albert Altes, Pierre Brissot, et al.
Journal of Hepatology|March 19, 2026
Characterization of ferroportin disease and SLC40A1-related hemochromatosis - Results from the EASL non-HFE registryMaria Rosina Troppmair, Andrea Ricci, Stefania Scarlini, et al.
Current Issues in Molecular Biology|May 15, 2023
Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD)Paola De Filippi, Edoardo Errichiello, Antonio Toscano, et al.
Frontiers in Medicine|April 4, 2022
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in ItalyGiovanna Graziadei, Lucia De Franceschi, Laura Sainati, et al.
Journal of Cellular and Molecular Medicine|March 31, 2022
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registryIbrahim El-Battrawy, Filomena Longo, Iván J Núñez Gil, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Hepatology (Baltimore, Md.)|September 4, 2010
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosisPradyumna Phatak, Pierre Brissot, Mark Wurster, et al.
Acta Neuropathologica|June 1, 2013
Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulationDorota Dziewulska, Hiroshi Doi, Alfonso Fasano, et al.
Journal of Inherited Metabolic Disease|February 10, 2018
Hepatocellular carcinoma in Gaucher disease: an international case seriesMartine Regenboog, Laura van Dussen, Joanne Verheij, et al.
Genes|December 24, 2021
New Mutations in <i>HFE2</i> and <i>TFR2</i> Genes Causing Non <i>HFE</i>-Related Hereditary HemochromatosisGonzalo Hernández, Xenia Ferrer-Cortès, Veronica Venturi, et al.
Journal of Personalized Medicine|September 23, 2022
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case ReportsMatteo Marcatili, Riccardo Borgonovo, Noemi Cimminiello, et al.
Hepatology International|March 29, 2018
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotypePaul Adams, Albert Altes, Pierre Brissot, et al.
Journal of Hepatology|March 19, 2026
Characterization of ferroportin disease and SLC40A1-related hemochromatosis - Results from the EASL non-HFE registryMaria Rosina Troppmair, Andrea Ricci, Stefania Scarlini, et al.
Current Issues in Molecular Biology|May 15, 2023
Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD)Paola De Filippi, Edoardo Errichiello, Antonio Toscano, et al.
Frontiers in Medicine|April 4, 2022
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in ItalyGiovanna Graziadei, Lucia De Franceschi, Laura Sainati, et al.
Journal of Cellular and Molecular Medicine|March 31, 2022
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registryIbrahim El-Battrawy, Filomena Longo, Iván J Núñez Gil, et al.
Pageof 10